natgillin/translations-raw huggingface dataset:
In the adolescent (13-17 years) schizophrenia population with aripiprazole exposure of 5 to 30 mg up to 72 months, incidence of low serum prolactin levels in females (< 3 ng/ml) and males (< 2 ng/ml) was 25.6 % and 45.0 %, respectively. 
Pri populaciji mladostnikov (starosti od 13 do 17 let) s shizofrenijo, ki so bili največ 72 mesecev izpostavljeni aripiprazolu 5 do 30 mg, je bila pogostnost nizkih vrednosti prolaktina v serumu pri ženskah (< 3 ng/ml) 25,6 % in pri moških (< 2 ng/ml) 45,0 %.
Nervousness 
Preobčutljivost
Tics associated with Tourette's disorder in paediatric patients (see section 4.2) The efficacy of aripiprazole was studied in paediatric subjects with Tourette's disorder (aripiprazole: n = 99, placebo: n = 44) in a randomised, double-blind, placebo controlled, 8 week study using a fixed dose weight-based treatment group design over the dose range of 5 mg/day to 20 mg/day and a starting dose of 2 mg. 
Trzaji, povezani s Tourettovim sindromom, pri pediatričnih bolnikih (glejte poglavje 4.2) Učinkovitost aripiprazola je bila raziskana pri pediatrični populaciji s Tourettovo motnjo (aripiprazol: N = 99, placebo: n = 44) v 8-tedenski randomizirani, dvojno slepi, s placebom nadzorovani študiji, zasnovani z zdravljenimi skupinami, ki so prejemale nespremenjen odmerek glede na telesno maso posameznika v razponu od 5 mg/dan do 20 mg/dan, z začetnim odmerkom 2 mg. Bolniki so bili stari od 7 do 17 let, izhodiščni rezultat njihovega števila trzajev po skupni oceni resnosti trzajev na lestvici TTS-YYGTSS (angl. Total Tic Severity Score - Yale Global Tic Severity Scale) pa je bil 30.
• The other ingredients for 15 mg are crystalline maltose, microcrystalline cellulose, pregelatinised starch, croscarmellose sodium, iron oxide yellow (E172) and magnesium stearate. 
Druge sestavine 15 mg zdravila so kristalna maltoza, mikrokristalna celuloza, predgelirani škrob, premreženi natrijev karmelozat, rumeni železov oksid (E172) in magnezijev stearat.
There are no differences in the pharmacokinetics of aripiprazole between healthy male and female subjects nor is there any detectable effect of gender in a population pharmacokinetic analysis in schizophrenic patients. 
Prav tako med spoloma ni bilo opaznih razlik v populacijski farmakokinetični analizi shizofrenih bolnikov.
Aripiprazole Mylan Pharma 30 mg tablets 
Aripiprazol Mylan Pharma 30 mg tablete
Manic episodes in Bipolar I Disorder in adolescents aged 13 years and older The frequency and type of adverse reactions in adolescents with Bipolar I Disorder were similar to those in adults except for the following reactions: very commonly (≥ 1/10) somnolence (23.0 %), extrapyramidal disorder (18.4 %), akathisia (16.0 %), and fatigue (11.8 %); and commonly (≥ 1/100, 
Manične epizode pri bipolarni motnji I pri mladostnikih, starih 13 let in več Pri mladostnikih z bipolarno motnjo I so bili neželeni učinki po pogostnosti in vrsti podobni kot pri odraslih, z izjemo naslednjih: somnolence (23,0 %), ekstrapiramidnih motenj (18,4 %), akatizije (16,0 %) in utrujenosti (11,8 %), ki so bili zelo pogosti (≥ 1/10), ter bolečine v zgornjem predelu trebuha, hitrejšega srčnega utripa, povečanja telesne mase, povečanega apetita, trzanja mišic in diskinezije, ki so bili pogosti (≥ 1/100, < 1/10).
In CYP2D6 poor metabolisers, concomitant use of strong inhibitors of CYP3A4 may result in higher plasma concentrations of aripiprazole compared to that in CYP2D6 extensive metabolizers. 
Pri osebah, ki slabo presnavljajo s CYP2D6 lahko sočasna uporaba z močnimi zaviralci CYP3A4 povzroči večjo koncentracijo aripiprazola v plazmi kot pri osebah, ki dobro presnavljajo s CYP2D6.Pri odločanju o sočasni uporabi ketokonazola ali drugih močnih zaviralcev CYP3A4 z aripiprazolom morajo biti možne koristi za bolnika večje od možnih tveganj.
Aripiprazole Mylan Pharma 30 mg tablets are pink, oval and biconvex of 17.1mm in length, 8.1 mm in width, engraved with ‘30' on one side. 
Tablete Aripiprazol Mylan Pharma 30 mg so roza, ovalne in bikonveksne dolžine 17,1 mm širine 8,1 mm ter z vrezano oznako '30' na eni strani.
Reproductive system and breast disorders 
Motnje reprodukcije in dojk priapizem
• uncontrollable movements of mouth, tongue and limbs (tardive dyskinesia), 
• nenadzorovani gibi ust, jezika in udov (tardivna diskinezija),
Excipient with known effect 28 mg of maltose per tablet 
28 mg maltoze na tableto.
Oesophageal dysmotility and aspiration have been associated with the use of antipsychotics, including aripiprazole. 
Z uporabo antipsihotikov, tudi z aripiprazolom, so bile povezane motnje motilitete požiralnika in aspiracija.
Pharmathen S.A. 6, Dervenakion Pallini 15351 Attiki, 
Pharmathen S.A. 6, Dervenakion
In one 3-week, fixed-dose, placebo-controlled monotherapy trial involving patients with a manic or mixed episode of Bipolar I Disorder, aripiprazole failed to demonstrate superior efficacy to placebo. 
V enem 3-tedenskem s placebom nadzorovanem preskušanju samostojnega zdravljenja s fiksnim odmerkom pri bolnikih z manično ali mešano epizodo bipolarne motnje I aripiprazol ni bil učinkovitejši od placeba.
Νο dosage adjustment is required for patients with mild to moderate hepatic impairment. 
Pri bolnikih z blago do zmerno okvaro jeter odmerka ni treba prilagajati.
Excipient with known effect 56 mg of maltose per tablet 
56 mg maltoze na tableto.
BGP Products Switzerland GmbH Eesti filiaal 
Österreich Arcana Arzneimittel GmbH
Aripiprazole demonstrated statistically superior efficacy compared to placebo on the Aberrant Behaviour Checklist Irritability subscale. 
Pri vrednotenju po podlestvici razdražljivosti na osnovi kontrolnega seznama odklonskega vedenja (‘Aberrant Behaviour Checklist Irritability subscale') se je izkazalo, da je aripiprazol statistično učinkovitejši od placeba, vendar pa pomen te ugotovitve za klinično uporabo ostaja neznan.
Increased Alanine Aminotransferase (ALT) Increased Aspartate Aminotransferase (AST) Increased Gamma Glutamyl Transferase (GGT) Increased alkaline phosphatase 
Bolezni jeter, žolčnika in žolčevodov odpoved jeter hepatitis zlatenica zvišana aktivnost alaninaminotransferaze (ALT) zvišana aktivnost aspartataminotransferaze (AST) zvišana aktivnost gamaglutamiltransferaze (GGT) zvišana aktivnost alkalne fosfataze
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription. 
Predpisovanje in izdaja zdravila je le na recept.
Aspiration pneumonia Laryngospasm Oropharyngeal spasm 
Bolezni dihal, prsnega koša in mediastinalega kolcanje aspiracijska pljučnica laringospazem orofaringealni spazem prostora
Microcrystalline cellulose Pregelatinised starch 
Jedro tablete kristalna maltoza mikrokristalna celuloza predgelirani škrob premrežen natrijev karmelozat magnezijev stearat
In the pooled adolescent schizophrenia population (13-17 years) with exposure up to 2 years, incidence of low serum prolactin levels in females (<3 ng/ml) and males (<2 ng/ml) was 29.5 % and 48.3 %, respectively. 
V populaciji mladostnikov s shizofrenijo (13-17 let), ki so se zdravili do 2 leti, je bila pogostnost nizke ravni prolaktina v serumu pri ženskah (< 3 ng/ml) 29,5 % in pri moških (< 2 ng/ml) 48,3 %.
Aggression 
Konvulzije
Excipient with known effect 84 mg of maltose per tablet 
84 mg maltoze na tableto.
• headache, 
• glavobol,
Aripiprazole Mylan Pharma 30 mg tablets Each tablet contains 30 mg of aripiprazole. 
Aripiprazol Mylan Pharma 30 mg tablete Ena tableta vsebuje 30 mg aripiprazola.
Mylan AB 
Mylan S.A.S.
• diabetes mellitus, 
• sladkorna bolezen,
How to take Aripiprazole Mylan Pharma 
Kako jemati zdravilo Aripiprazol Mylan Pharma
Photosensitivity reaction Alopecia 
Bolezni kože in podkožja izpuščaj fotozensibilnostna reakcija alopecija hiperhidroza
In a 26-week, olanzapine-controlled, double-blind, multi-national study of schizophrenia which included 314 adult patients and where the primary end-point was weight gain, significantly less patients had at least 7 % weight gain over baseline (i.e. a gain of at least 5.6 kg for a mean baseline weight of~80.5 kg) on aripiprazole (n = 18, or 13 % of evaluable patients), compared to olanzapine (n = 45, or 33 % of evaluable patients). 
za vsaj 5,6 kg pri povprečni izhodiščni masi ~ 80,5 kg) značilno redkejše pri bolnikih, ki so dobivali aripiprazol, (n = 18 ali 13 % ocenljivih bolnikov) kot pri tistih, ki so dobivali olanzapin (n = 45 ali 33 % ocenljivih bolnikov).
Hyperglycaemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics, including aripiprazole. 
V nekaterih primerih je bila zelo izrazita in povezana s ketoacidozo ali hiperosmolarno komo ali smrtjo.
• acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, 
• kombinacija zvišane telesne temperature, togosti mišic, pospešenega dihanja, znojenja,
Tardive dyskinesia Dystonia 
Zapoznela diskinezija
Tablet coat 
Obloga tablete
Suicidal thoughts and behaviours have been reported during aripiprazole treatment. 
Med zdravljenjem z aripiprazolom so poročali o mislih na samomor in samomorilnem vedenju.
Aripiprazole Mylan Pharma 15 mg tablets Each tablet contains 15 mg of aripiprazole. 
Aripiprazol Mylan Pharma 15 mg tablete Ena tableta vsebuje 15 mg aripiprazola.
• stomach discomfort, 
• nelagodje v trebuhu,
• tiredness, 
• drgetanja,
Hepatic failure 
Ledvična okvara
• trembling, 
• togost,
Aripiprazole Mylan Pharma 15 mg tablets are yellow, round and biconvex of 10.1 mm in diameter, engraved with ‘15' on one side. 
Tablete Aripiprazol Mylan Pharma 15 mg so rumene, okrogle in bikonveksne premera 10,1 mm in z vrezano oznako '15' na eni strani.
Aripiprazole Mylan Pharma 10 mg tablets Each tablet contains 10 mg of aripiprazole. 
Aripiprazol Mylan Pharma 10 mg tablete Ena tableta vsebuje 10 mg aripiprazola.
PHARMACEUTICAL PARTICULARS 6.1 List of excipients Tablet core 
6.1 Seznam pomožnih snovi
• abdominal discomfort, 
• prebavne motnje,
In the paediatric bipolar population (10-17 years) with exposure up to 30 weeks, incidence of low serum prolactin levels in females (< 3 ng/ml) and males (< 2 ng/ml) was 28.0 % and 53.3 %, respectively. 
V pediatrični populaciji z bipolarno motnjo (10-17 let), ki so se zdravili do 30 tednov, je bila pogostnost nizke ravni prolaktina v serumu pri deklicah (< 3 ng/ml) 28,0 %, pri dečkih (< 2 ng/ml) pa
Other strong inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors, may be expected to have similar effects and similar dose reductions should therefore be applied (see section 4.2). 
Pričakovati je mogoče, da imajo drugi močni zaviralci CYP3A4, npr. itrakonazol in zaviralci proteaz HIV, podobne učinke, zato je treba odmerjanje podobno zmanjšati (glejte poglavje 4.2).Po prenehanju zdravljenja z zaviralcem CYP2D6 ali CYP3A4 je treba odmerjanje aripiprazola zvečati na raven, kakršna je bila pred uvedbo sočasne terapije.
INFORMATION IN BRAILLE Aripiprazole Mylan Pharma 30 mg 
PODATKI V BRAILLOVI PISAVI Aripiprazol Mylan Pharma 30 mg
• feeling anxious, 
• občutek tesnobe,
Temperature regulation disorder (e.g. hypothermia, pyrexia) Chest pain 
Splošne težave in spremembe na mestu aplikacije izčrpanost motnje termoregulacije (npr hipotermija, pireksija) bolečina v prsih periferni edemi
This leaflet was last revised in MM/YYYY. 
Navodilo je bilo nazadnje revidirano dne
The incidences of the Adverse Drug Reactions (ADRs) associated with aripiprazole therapy are tabulated below. 
Pri bolnikih, zdravljenih z atipičnimi antipsihotiki, vključno z aripiprazolom, so poročali o hiperglikemiji.
Aripiprazole was superior to placebo in change from baseline at week 4 and at week 12 on the Y-MRS total score. 
Aripiprazol se je v 4. tednu in v 12. tednu pri spremembi skupne ocene po lestvici Y-MRS od izhodišča izkazal za boljšega od placeba.
• triptans, tramadol and tryptophan used for conditions including depression, generalised anxiety disorder, obsessive compulsive disorder (OCD) and social phobia as well as migraine and pain 
generalizirano anksiozno motnjo, obsesivno-kompulzivno motnjo (OCD) in socialno fobijo, kot tudi za migrene in bolečine,
Aripiprazole Mylan Pharma 10 mg tablets are pink, round and biconvex of 8.1 mm in diameter, engraved with ‘10' on one side. 
Tablete Aripiprazol Mylan Pharma 10 mg so roza, okrogle in bikonveksne premera 8,1 mm in z vrezano oznako '10' na eni strani.
Patients who have taken too much aripiprazole have experienced the following symptoms: 
Pri bolnikih, ki so se zdravili z aripiprazolom, so poročali o primerih serotoninskega sindroma.
STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 30 mg of aripiprazole. 
Ena tableta vsebuje 30 mg aripiprazola.
How to store Aripiprazole Mylan Pharma 
Shranjevanje zdravila Aripiprazol Mylan Pharma
Renal impairment Νο dosage adjustment is required in patients with renal impairment. 
Ledvična okvara Pri bolnikih z okvaro ledvic odmerka ni treba prilagajati.
• if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6). 
Kaj morate vedeti, preden boste vzeli zdravilo Aripiprazol Mylan Pharma Ne jemljite zdravila Aripiprazol Mylan Pharma če ste alergični na aripiprazol ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
• weight loss, 
• izguba zavesti,
Constipation Dyspepsia Nausea Salivary hypersecretion Vomiting 
Očesne bolezni zamegljen vid diplopija okulogirna kriza
These medicines may increase the risk of side effects or reduce the effect of Aripiprazole Mylan Pharma; if you get any unusual symptom taking any of these medicines together with Aripiprazole Mylan Pharma you should see your doctor. 
Ta zdravila lahko povečajo tveganje za neželene učinke ali zmanjšajo učinek zdravila Aripiprazol Mylan Pharma.
INFORMATION IN BRAILLE Aripiprazole Mylan Pharma 10 mg 
PODATKI V BRAILLOVI PISAVI Aripiprazol Mylan Pharma 10 mg
• fixation of the eyeballs in one position, 
• fiksacija očesnih zrkel,
STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 15 mg of aripiprazole. 
Ena tableta vsebuje 15 mg aripiprazola.
STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 5 mg of aripiprazole. 
Ena tableta vsebuje 5 mg aripiprazola.
Consider dose reduction or stopping the medication if a patient develops such urges while taking aripiprazole (see section 4.8). 
Če se med zdravljenjem z aripiprazolom pri bolniku pojavijo taki impulzi, razmislite o zmanjšanju odmerka ali ukinitvi zdravila (glejte poglavje 4.8).
STATEMENT OF ACTIVE SUBSTANCE Each tablet contains 10 mg of aripiprazole. 
Ena tableta vsebuje 10 mg aripiprazola.
INFORMATION IN BRAILLE Aripiprazole Mylan Pharma 15 mg 
PODATKI V BRAILLOVI PISAVI Aripiprazol Mylan Pharma 15 mg
• sleepiness, 
• zaspanost,
• antidepressants or herbal remedy used to treat depression and anxiety (such as fluoxetine, 
• antidepresive ali pripravke rastlinskega izvora proti depresiji in tesnobnosti (kot so fluoksetin, paroksetin, venlafaksin, šentjanževka),
Grand mal convulsion Serotonin syndrome Speech disorder 
Bolezni živčevja akatizija ekstrapiramidne motnje tremor glavobol sedacija somnolenca omotica tardivna diskinezija distonija maligni nevroleptični sindrom (MNS) generalizirani epileptični napad serotoninski sindrom motnje govora
• combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate, fainting (neuroleptic malignant syndrome), 
zmanjšane stopnje zavesti in nenadne spremembe krvnega tlaka ter hitrosti srčnega utripa,
What Aripiprazole Mylan Pharma contains 
Kaj vsebuje zdravilo Aripiprazol Mylan Pharma
Aripiprazole Mylan Pharma 30 mg tablets EU/1/15/1005/010 
Aripiprazol Mylan Pharma 30 mg tablete EU/1/15/1005/010
• stiffness, 
• omotičnost,
Contact your doctor or hospital immediately if you experience any of the above. 
Obvestite svojega zdravnika, če opazite katero od navedenih vedenjskih sprememb.
• seizure, 
• bruhanje,
Aripiprazole Mylan Pharma 15 mg tablets EU/1/15/1005/007 
Aripiprazol Mylan Pharma 15 mg tablete EU/1/15/1005/007
Special population 
Posebne skupine bolnikov
• Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include: - strong impulse to gamble excessively despite serious personal or family consequences - altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive - uncontrollable excessive shopping - binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger) - a tendency to wander away. 
− prenajedanje (uživanje velikih količin hrane v kratkem obdobju) ali kompulzivno uživanje hrane (uživanje večjih količin hrane od normalnih in več, kot je potrebno za potešitev lakote),
Aripiprazole Mylan Pharma 10 mg tablets EU/1/15/1005/004 
Aripiprazol Mylan Pharma 10 mg tablete EU/1/15/1005/004
There are no differences in the pharmacokinetics of aripiprazole between healthy elderly and younger adult subjects, nor is there any detectable effect of age in a population pharmacokinetic analysis in schizophrenic patients. 
Tudi v populacijski farmakokinetični analizi pri shizofrenih bolnikih niso našli opaznega učinka starosti.
Aripiprazole Mylan Pharma 5 mg tablets EU/1/15/1005/001 
Aripiprazol Mylan Pharma 5 mg tablete EU/1/15/1005/001
• baldness, 
• plešavost,
NAME OF THE MEDICINAL PRODUCT Aripiprazole Mylan Pharma 10 mg tablets aripiprazole 
Aripiprazol Mylan Pharma 10 mg tablete aripiprazol
INFORMATION IN BRAILLE Aripiprazole Mylan Pharma 5 mg 
NAVODILA ZA UPORABO PODATKI V BRAILLOVI PISAVI Aripiprazol Mylan Pharma 5 mg
• muscle pain, 
• bolečine v mišicah,
In two 12-week, placebo- and active-controlled monotherapy trials in patients with a manic or mixed episode of Bipolar I Disorder, with or without psychotic features, aripiprazole demonstrated superior efficacy to placebo at week 3 and a maintenance of effect comparable to lithium or haloperidol at week 12. 
V dveh 12-tedenskih s placebom in učinkovino nadzorovanih preskušanjih samostojnega zdravljenja pri bolnikih z manično ali mešano epizodo pri bipolarni motnji I s psihotičnimi simptomi ali brez njih se je po 3 tednih izkazalo, da je aripiprazol učinkovitejši od placeba.
Tardive dyskinesia 
Jetrna okvara
• excessive sweating, 
• prekomerno potenje,
• spasm of the muscles around the voice box, 
• krči mišic v grlu,
Pancreatitis Dysphagia 
Zvečanje telesne mase
Aripiprazole Mylan Pharma 5 mg tablets Each tablet contains 5 mg of aripiprazole. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Aripiprazol Mylan Pharma 5 mg tablete Ena tableta vsebuje 5 mg aripiprazola.
NAME OF THE MEDICINAL PRODUCT Aripiprazole Mylan Pharma 30 mg tablets aripiprazole 
Aripiprazol Mylan Pharma 30 mg tablete aripiprazol
Mylan BV 
Mylan Healthcare GmbH
NAME OF THE MEDICINAL PRODUCT Aripiprazole Mylan Pharma 5 mg tablets aripiprazole 
Aripiprazol Mylan Pharma 5 mg tablete aripiprazol
Aripiprazole dose should be reduced to approximately one-half of its prescribed dose when concomitant administration of aripiprazole with quinidine occurs. 
Če se aripiprazol uporablja sočasno s kinidinom, je treba odmerek aripiprazola zmanjšati na približno polovico predpisanega odmerka.
Dysphagia 
Odmerjanje
• inflammation of the liver, 
• pospešen srčni utrip,
• low levels of blood platelets, 
• nizke ravni trombocitov;
• inflammation of the pancreas, 
• epileptični krči,
• chest pain, 
• bolečina v prsih,
Aripiprazole Mylan Pharma 5 mg tablets Indigo carmine (E132) Aripiprazole Mylan Pharma 10 mg tablets Iron Oxide Red (E172) Aripiprazole Mylan Pharma 15 mg tablets Iron Oxide Yellow (E172) Aripiprazole Mylan Pharma 30 mg tablets Iron Oxide Red (E172) 6.2 Incompatibilities Not applicable. 
Aripiprazol Mylan Pharma 15 mg tablete rumen železov oksid (E172)
NAME OF THE MEDICINAL PRODUCT Aripiprazole Mylan Pharma 15 mg tablets aripiprazole 
Aripiprazol Mylan Pharma 15 mg tablete aripiprazol
Abdominal discomfort Stomach discomfort 
Bolezni prebavil zaprtost dispepsija navzea prekomerno izločanje sline bruhanje pankreatitis disfagija driska nelagodje v trebuhu nelagodje v želodcu
2 years. 
Dve leti.
This is especially important if you use more than 1 type of insulin. 
To je še posebej pomembno, če uporabljate več kot eno vrsto insulina.
ATC Code: A10AE04. 
Oznaka ATC: A10AE04.
Date of first authorisation: 9 September 2014 Date of latest renewal: 25 July 2019 
Datum prve odobritve: 9. september 2014 Datum zadnjega podaljšanja: 25. julij 2019
There may be new information. 
Morda so tu navedene nove informacije.
You may give an infection to them or get an infection from them. 
S tem jim lahko prenesete okužbo ali pa dobite okužbo od njih.
The following graph shows the results from a study in patients: 
Spodnji graf prikazuje rezultate študij pri bolnikih:
PC: {number} SN: {number} NN: {number} 
PC: {številka } SN: {številka } NN: {številka }
- In your body 
V vašem telesu
• Wash your hands with soap and water 
• Umijte si roke z milom in vodo.
No new safety signals were observed in this trial. 
V tem preskušanju niso odkrili nobenih novih varnostnih signalov.
- Your needle may be blocked. 
- morda je vaša igla zamašena.
Hypoglycaemia is also more likely to occur if 
Hipoglikemija je verjetnejša tudi, če
If the hypoglycaemia comes back again, take another 10 to 20 g sugar. 
Če se hipoglikemija znova pojavi, zaužijte dodatnih 10 do 20 gramov sladkorja.
To prevent the possible transmission of disease, each pen must be used by one patient only. 
Da bi preprečili morebiten prenos bolezni, lahko posamezen peresnik uporablja le en bolnik.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: 
Za vse informacije o tem zdravilu se obrnite na lokalnega predstavnika imetnika dovoljenja za promet z zdravilom:
Do not pass it on to others. 
Ne predajajte ga drugim.
• It is normal to see a small amount of insulin left in the pen that you cannot inject. 
• Povsem normalno je, da ostane v peresniku majhna količina insulina, ki je ne morete injicirati.
Supplies needed to give your injection: 
Potrebščine, ki jih potrebujete za dajanje injekcije:
Low blood sugar means that there is not enough sugar in your blood. 
Nizek krvni sladkor pomeni, da v krvi nimate dovolj sladkorja.
The insulin requirement is often increased. 
Potreba po insulinu se pogosto poveča.
This leaflet was last revised in <{MM/YYYY}> <{month YYYY}>. 
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}> <{mesec YYYY}>.
Do not shake or mix it before use. 
Pred uporabo je ne tresite ali mešajte.
• Throw away the pen you are using after 28 days, even if it still has insulin left in it. 
• Zavrzite peresnik, ki ga uporabljate, po 28 dneh, tudi če je v njem še insulin.
- In your brain 
V vaših možganih
Immediate-type allergic reactions to insulin are rare. 
Takojšnje alergijske reakcije na insulin so redke.
This is a modified insulin, very similar to human insulin. 
To je spremenjen insulin, zelo podoben humanemu insulinu.
• Check the pen to make sure you are taking the right type of insulin. 
• Preverite peresnik, da se prepričate, da jemljete pravo vrsto insulina.
Do not use if it has been frozen. 
Ne uporabljajte zdravila, če je bilo zmrznjeno.
Before travelling consult your doctor. 
Preden greste na potovanje, se posvetujte z zdravnikom.
Most minor reactions to insulins usually disappear in a few days to a few weeks. 
Večina manjših reakcij na insuline običajno izgine v nekaj dneh do nekaj tednih.
Small air bubbles are normal and will not affect your dose. 
Majhni zračni mehurčki so normalen pojav in ne bodo vplivali na vaš odmerek.
• Do not use your pen if any part looks broken or damaged. 
• Ne uporabljajte peresnika, če je kateri koli njegov del videti zlomljen ali okvarjen.
Please consult your doctor for further information. 
Za nadaljnje informacije se posvetujte z zdravnikom.
Secondary endpoints included all-cause mortality and a composite microvascular outcome. 
Sekundarni opazovani dogodki so vključevali celokupno smrtnost in sestavljeni mikrovaskularni izid.
The dose indicator should line up with your dose. 
Kazalnik odmerkov se mora poravnati z vašim odmerkom.